Yüklüyor......
Pretherapeutic (68)Ga-PSMA-617 PET may indicate the dosimetry of (177)Lu-PSMA-617 and (177)Lu-EB-PSMA-617 in main organs and tumor lesions
AIM: Combined (68)Ga-PSMA-617 positron emission tomography (PET) imaging and (177)Lu-PSMA-617 therapy is a precise targeted theranostic approach for patients with metastatic castration-resistant prostate cancer (mCRPC). The purpose of this study was to determine whether pretherapeutic standard uptak...
Kaydedildi:
| Yayımlandı: | Clin Nucl Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6502681/ https://ncbi.nlm.nih.gov/pubmed/30985422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLU.0000000000002575 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|